eISSN 1738-8872
pISSN 1017-7825

Table. 2.

Table. 2.

Antiviral effects of Bifidobacterium spp.

Reference Strain(s) Outcomes and results Discussion
Gagnon et al. [17] B. thermophilum, B. thermacido-philum, B. longum, B. pseudolongum • Inhibition of adherence of rotavirus to Caco-2 and HT-29 cells after pretreatment with B. thermophilum• Number of rotavirus, duration of diarrhea, and epithelial lesion decreased after treatment with B. thermophilum Bifidobacteria contributed to the inhibition of rotavirus infections, and ultimately resulted in reduced transmission
Ishizuka et al. [18] B. infantis, B. breve • Controlled release of antiviral substances• Rotaviral infectivity of PIE cells decreased with B. infantis or B. breve pretreatment It is possible to replace antiviral drugs with a bifidobacteria formula to inhibit rotavirus infections in animals
Vlasova et al. [19] L. rhamnosus, B. animalis • Virus shedding titer decreased• Viral diarrhea period reduced Diarrhea of neonatal gnotobiotic pig by human rotavirus was mitigated
Muñoz et al. [20] B. longum subsp. infantis • Virus shedding decreased• Fecal sIgA increased B. infantis showed an initial protective effect against infection with the murine rotavirus McN strain
Holscher et al. [21] B. lactis • Fecal anti-rotaviral and anti-polioviral IgA increased after vaccination The lack of immunity in infants not breastfed or delivered by cesarean sectioning was mitigated by safely introducing immune-controlling bacteria through a Bb12 formula

IgA, immunoglobulin A; PIE, porcine intestinal epitheliocytes.

J. Microbiol. Biotechnol. 2020;30:1793~1800
© J. Microbiol. Biotechnol.